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Abstract The 62 residue peptide, SSR(1^62), whose sequence
corresponds to that of ribonuclease (RNase) from Sulfolobus
solfataricus, and its related peptides, SSR(1^22) and SSR(10^
62), were chemically synthesized and their RNase activity and
DNA-binding activity were examined. The RNase activity assay
using yeast RNA or tRNAfMet as substrate showed that the
synthetic peptide SSR(1^62) did not hydrolyze yeast RNA or
tRNAfMet. These data were not consistent with previous reports
that both the native peptide isolated from S. solfataricus [Fusi et
al. (1993) Eur. J. Biochem. 211, 305^311] and the recombinant
peptide expressed in Escherichia coli [Fusi et al. (1995) Gene
154, 99^103] were able to hydrolyze tRNAfMet. However, the
synthetic SSR(1^62) exhibited DNA-binding activity. In the
presence of synthetic SSR(1^62), the cleavage of DNA (plasmid
pUCRh2-4) by restriction endonuclease (EcoRI) was not
observed, suggesting that synthetic SSR(1^62) bound to DNA
protected DNA from its enzymatic digestion. Neither SSR(1^22)
nor SSR(10^62) prevented DNA from being cleaved by a
restriction enzyme. These findings strongly suggest the impor-
tance of not only the N-terminal region of SSR(1^62) but also
the C-terminal region for DNA-binding. Circular dichroism
spectroscopy of synthetic SSR(1^62) indicated a L-sheet
conformation, in contrast with synthetic SSR(1^22), which
exhibited an unordered conformation.
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1. Introduction
Ribonuclease (RNase) is an enzyme that catalyzes the hy-
drolysis of phosphodiester bonds in an RNA chain. More
RNases occur in organisms than previously thought. How-
ever, little is known about archaebacterial RNases. Only
two RNases P, which are involved in tRNA processing,
have been identi¢ed and characterized thus far, one from Sul-
folobus solfataricus and the other from Haloferax volcanii [1].
Fusi et al. isolated three proteins with RNase activity, referred
to as P1, P2 and P3, from the thermoacidophilic archaebac-
terium S. solfataricus [2]. Protein P2 consists of 62 amino acid
residues and shows no signi¢cant similarity to any known
class of RNases; in particular, P2 is de¢cient in His residues,
which are essential for catalysis in all of the RNases known to
date. On the other hand, the complete amino acid sequence of
P2 revealed a high sequence similarity to that of the 7 kDa
DNA-binding proteins [3^5]. In fact, protein P2 and P3 dem-
onstrated non-speci¢c DNA-binding activity [2]. The ¢rst
question coming from the identi¢cation of those proteins is
what mechanism is involved when they function as RNases.
The second one is which region of the peptide is involved in
RNase activity. Furthermore, most surprisingly, it was found
that they exhibit two di¡erent functions; RNase activity and
DNA-binding activity. These questions motivated us to inves-
tigate the structure-activity relationship of P2. In our previous
study [6,7], attempts were made to synthesize peptide frag-
ments related to SSR(1^62): SSR(57^62), SSR(52^62),
SSR(47^62), SSR(44^62), SSR(37^62), SSR(33^62), SSR(27^
62) and SSR(17^62) by both solution and solid-phase meth-
ods. However, those truncated peptides showed neither
RNase activity nor DNA-binding activity, suggesting the im-
portance of the N-terminus region to manifest RNase activity
or DNA-binding activity [7]. In this report, we present the
chemical synthesis of SSR(1^62), SSR(1^22) and SSR(10^62)
and examination of their RNase activity and DNA-binding
activity.
2. Materials and methods
2.1. Peptide synthesis and puri¢cation
SSR(1^62), SSR(1^22) and SSR(10^62) were synthesized by Boc
solid-phase synthesis using Boc-Lys(2-Cl-Z)-Pam-resin or Boc-Val-
Pam-resin as the solid support on a Vega automated peptide synthe-
sizer according to the procedure described elsewhere [7]. Cleavage
from the resin and deblocking of the protecting groups were achieved
with the low-high HF procedure [8]. Brie£y, the protected peptide-
resins were treated with p-thiocresol/p-cresol/dimethyl sul¢de (DMS)/
HF (0.8:3.2:26:10) at 34‡C for 2 h. After removal of DMS, HF was
again condensed into the reactor. The reaction mixture was kept at
34‡C for 1 h. After cleavage and deblocking, the crude peptides were
¢ltered, dried, dissolved in dilute acetic acid and lyophilized. The
peptides were puri¢ed by preparative high performance liquid chro-
matography (HPLC) on a C18 column (3.9U150 mm, Waters). The
structure of the synthetic peptides was characterized by amino acid
analysis and mass spectrometric methods. In the case of SSR(1^62),
protein sequencing was performed on an ABI477A protein sequencer.
2.2. Enzyme activity assay
The RNase activity was determined according to the procedure
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described by Fusi et al. [2], with minor modi¢cation. The reaction
mixture, which consisted of 50 Wg of peptides and 400 Wg of yeast
RNA in 40 mM sodium phosphate bu¡er, pH 7.8, in a ¢nal volume of
0.25 ml, was incubated for 10 min at 60‡C. The reaction was stopped
by addition of 0.25 ml of 2 mM lantanum nitrite/15% HClO4. After
standing on an ice bath for 20 min, the reaction mixture was centri-
fuged for 10 min at 3000 rpm, then 400 Wl aliquot of the supernatant
was withdrawn and diluted to 2 ml with water. The absorbance of the
solution was measured at 260 nm.
The hydrolysis activity against tRNA was examined according to
the method described by Fusi et al. [2] with slight modi¢cation.
tRNAfMet (20 Wg) was incubated at 60‡C for 60 min with or without
10 Wg of synthetic SSR(1^62) in 40 mM sodium phosphate bu¡er, pH
7.8. A 3 Wg of protein kinase K was added to the samples, and they
were further incubated at 37‡C for 30 min. The reaction mixtures were
precipitated with two volumes of ethanol and the cleavage products
were then resolved in 19% polyacrylamide gel electrophoresis (PAGE)
in the presence of 7 M urea as reported by Maniatis et al. [9]. The gel
was stained by the silver staining method according to Morrissey [10].
2.3. DNA-binding activity assay
The DNA-binding activity of peptides was determined on 1% agar-
ose gels [11]. The peptides were incubated with pUCRh2-4 plasmid
DNA (ca. 3.9 kbp, 48 Wg) at 50‡C for 30 min. After incubation of the
peptide-DNA complex with restriction endonuclease EcoRI (8 U) at
37‡C for 2 h, the products were analyzed on 1% agarose gels.
2.4. Circular dichroism (CD) spectroscopy
CD spectra were measured with JASCO J-600 at room temperature
in a 1.0 cm cell at wavelengths from 250 to 200 nm. A solution of the
peptides was prepared in H2O, pH ca. 6.0V6.5.
3. Results
3.1. Synthesis of SSR and SSR-related peptides
Final products were obtained as an amorphous powder
with 95% or higher purity estimated by analytical HPLC. In
order to prevent racemization during peptide synthesis, the
stepwise elongation from the C-terminal by one amino acid
at a time using urethane-protected amino acids such as tert-
butyloxycarbonyl amino acid was employed, because this pro-
cedure was established as a racemization-free strategy [7]. The
molecular mass of synthetic SSR(1^62) determined by electro-
spray mass spectra was 7020.5 (m/z), which was in good agree-
ment with the calculated theoretical mass of 7020.27 [M+H]
for SSR(1^62). In addition, protein sequencing of synthetic
SSR(1^62) led to identi¢cation of all 62 amino acid residues
of SSR(1^62). The strategy applied in the sequence determi-
nation of SSR(1^62) is shown (Fig. 1). The N-terminal se-
quence of synthetic SSR(1^62) was determined as far as 44
residues by subjecting the intact SSR(1^62) to Edman degra-
dation. The complete sequence was determined as follows: the
NO-maleinyl SSR(1^62) was digested with trypsin, and the
resulting peptide fragments were separated by reversed-phase
HPLC. The sequence determination of the fragment (T91),
corresponding to SSR(44^62), allowed the identi¢cation of
all amino acid residues. The puri¢ed peptides, SSR(10^62)
and SSR(1^22), were also identi¢ed by amino acid analysis
and molecular mass analysis.
3.2. RNase activity of peptides
In order to examine the RNase activity of the synthetic
peptides SSR(1^62), SSR(1^22) and SSR(10^62), we measured
the RNase activity for all peptides using yeast RNA as sub-
strate according to the method of Fusi et al. [2] with slight
modi¢cation. Synthetic SSR(1^62) exhibited less than 0.05%
Fig. 1. Determination of primary structure of synthetic SSR(1^62).
T indicates peptide from trypsin digestion after maleinylation at the
Lys* residues. The Edman degradation was performed on the entire
SSR(1^62) and on T91.
Fig. 2. Electrophoretic pro¢le of tRNAfMet incubated with synthetic
SSR(1^62). The reaction mixtures were separated using urea PAGE
according to Maniatus et al. [9]. Bands were silver-stained according
to Morrissey [10]. Lane 1, tRNAfMet-incubated; lane 2, tRNAfMet-
incubated without synthetic SSR(1^62); lane 3, tRNAfMet-incubated
with synthetic SSR(1^62).
Fig. 3. Protection of pUCRh2-4 plasmid DNA from EcoRI diges-
tion by addition of synthetic SSR(1^62) and SSR-related peptides.
Lane 1, marker: Lambda DNA digested with HindIII; lane 2, na-
tive pUCRh2-4 plasmid DNA; lane 3, native pUCRh2-4 plasmid
DNA incubated with EcoRI; lane 4, DNA-SSR(1^62) complex;
lane 5, regained plasmid DNA after phenol extraction of DNA-
SSR(1^62) complex; lane 6, DNA-SSR(1^62) complex incubated
with EcoRI; lane 7, DNA incubated with SSR(10^62); lane 8, phe-
nol extraction of the reaction mixture DNA and SSR(10^62); lane
9, the mixture of DNA and SSR(10^62) incubated with EcoRI; lane
10, DNA incubated with SSR(17^62); lane 11, phenol extraction of
the reaction mixture DNA and SSR(17^62); lane 12, the mixture of
DNA and SSR(17^62) incubated with EcoRI; lane 13, DNA incu-
bated with SSR(1^22); lane 14, phenol extraction of the reaction
mixture DNA and SSR(1^22); lane 15, the mixture of DNA and
SSR(1^22) incubated with EcoRI; lane 16, marker: the same as
lane 1. All samples were separated on 1% agarose gel and stained
with ethidium bromide.
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RNase activity of bovine pancreatic RNase A under the con-
ditions described in Section 2. To investigate the cleavage
condition of yeast RNA better, synthetic peptides were incu-
bated for 5^60 min at 60‡C in 50 mM acetate bu¡er, pH 5.0,
or in 50 mM Tris^HCl bu¡er, pH 7.5. No e¡ect was exerted
by reaction time or pH. Also, varying ratios of synthetic pep-
tides to yeast RNA were employed; peptides (10 Wg, 20 Wg
and 50 Wg) to yeast RNA (400 Wg). The RNase activity of
synthetic peptides was una¡ected by the ratio to the substrate.
Finally, we were not able to ¢nd any RNase activity of syn-
thetic peptides under the conditions we used (see Section 2),
although the ratio of synthetic peptides (50 Wg) to yeast RNA
(400 Wg) was much higher than when the usual method is
employed.
Furthermore, we tried to examine hydrolysis activity of
synthetic SSR(1^62) on tRNAfMet as mentioned by Fusi et
al. [2]. Upon incubation of tRNAfMet with synthetic SSR(1^
62), no fragment was generated (Fig. 2). We did not observe
RNase activity of synthetic peptide(1^62) against yeast RNA
or tRNAfMet. These results clearly demonstrated that the
property of the synthetic SSR(1^62) was enzymatically distin-
guishable from that of native P2 [2].
3.3. DNA-binding activity of peptides
The DNA-binding activity of SSR(1^62), SSR(1^22) and
SSR(10^62) was investigated. SSR(1^62) bound to plasmid
DNA pUCRh2-4 causing a signi¢cant mobility change in
the SSR(1^62)-plasmid DNA complex compared to plasmid
DNA alone on 1% agarose gel (Fig. 3, lines 4 and 2, respec-
tively). Dissociation of the SSR(1^62)-plasmid DNA complex
by phenol-10 mM Tris^HCl bu¡er, pH 8.0, containing 1 mM
EDTA extraction, released native plasmid DNA which was
digested by restriction endonuclease EcoRI leading to a frag-
ment DNA with ca. 800 bp (Fig. 3, lines 5 and 3, respectively).
Incubation of the SSR(1^62)-plasmid DNA complex with re-
striction endonuclease EcoRI did not lead to the fragment
DNA with ca. 800 bp (Fig. 3, line 6). These results showed
that SSR(1^62) bound to DNA as the DNA-binding protein
P2. In a previous report [7], we demonstrated that SSR(17^62)
did not bind to plasmid DNA. In addition to SSR(17^62),
SSR(1^22) with deletion of the C-terminal region (23^62)
and SSR(10^62) lacking 9 amino acid residues at the N-ter-
minus did not bind to plasmid DNA. When each mixture of
peptide and plasmid DNA was incubated with EcoRI, it did
release the DNA fragment with ca. 800 bp (Fig. 3, lines 15
and 9, respectively). From these results, only SSR(1^62) with
a full sequence of P2 had the ability to bind DNA (Table 1).
3.4. Conformational properties of synthetic peptides
The CD spectra of the synthetic peptides were measured
(Fig. 4). Synthetic SSR(1^62), the only peptide with DNA-
binding ability, showed a conformation rich in L-sheet char-
acterized by a peak at 217 nm. The CD spectrum of SSR(1^
22) did not exhibit either double minima at 222 nm and 208
nm or a minimum at 217 nm, which characterized the K-helix
structure and L-sheet structure, respectively [12]. The domi-
nant structure of SSR(1^22) would be a random coil. The CD
spectra of SSR(10^62) are also shown in Fig. 4. Comparison
of those spectra indicated that deletion of the N- or C-termi-
nal region produced a conformational change.
4. Discussion
We have succeeded in preparing peptides SSR(1^62),
SSR(10^62) and SSR(1^22), by chemical methods. Synthetic
SSR(1^62) displayed less than 0.05% of RNase activity of
bovine pancreatic RNase A with the same assay method
used by Fusi et al. [2,13] and no ability to hydrolyze
tRNAfMet. Fusi et al. reported that protein P2, not only iso-
lated from the thermoacidophilic archaebacterium S. solfatari-
cus [2] but also expressed from Escherichia coli and yeast cells
with use of the synthetic P2 encoding gene [14], was able to
hydrolyze tRNAfMet. Thus, our results con£ict with those of
Fusi et al. [2,13,14]. The wild-type P2 enzyme was partially
methylated at Lys4 and Lys6, while synthetic P2 was not
methylated. However, lysine methylation would not play a
role in RNase activity, because recombinant P2 exhibited
RNase activity, although the lysine residues of recombinant
P2 were probably not methylated. Fusi et al. demonstrated
that P2 on gel ¢ltration displayed two peaks, the assessed
molecular masses of which were 13.0 and 7.3 kDa, respec-
tively [2]. One possible explanation of the disparity between
our results and those of Fusi et al. would be that synthetic
SSR(1^62) di¡ered from P2 in quaternary structure so that
synthetic SSR(1^62) lacks the properties of RNase. Our re-
sults suggest the necessity to investigate further: (i) whether
the P2 protein has two stable conformations, only one of
which is enzymatically active while the other is inactive, and
the chemically synthesized P2 was in an inactive state; (ii)
whether the P2 protein isolated from S. solfataricus cells
and host cells of E. coli and S. cerevisiae had adsorbed any
nucleolytically active protein; (iii) by what mechanism did P2,
lacking His residues, hydrolyze RNA when, in fact, His resi-
dues are the most common constituents of nucleolytic en-
zymes.
Although synthetic SSR(1^62) was inactive as an RNase,
SSR(1^62) exhibited DNA-binding activity. On the other
hand, neither SSR(10^62) nor SSR(1^22) could bind DNA.
Fig. 4. CD spectra of synthetic peptides SSR(1^62) (line 1),
SSR(10^62) (line 2) and SSR(1^22) (line 3).
Table 1




SSR(1^62) Increased M.w. Not cleaved +
SSR(1^22) Unchanged M.w. Cleaved 3
SSR(10^62) Unchanged M.w. Cleaved 3
aPlus sign (+) indicates no inhibition of EcoRI-binding to DNA.
Minus sign (3) indicates inhibition of EcoRI-binding to DNA.
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This suggests that some part of the N-terminal region might
interact with some part of the C-terminal region of SSR(1^62)
to form a conformation necessary for DNA-binding.
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